Schedule 13D ownership disclosure

Tango Therapeutics Inc

Common Stock, $0.001 par value per share · CUSIP: 87583X109

Event date: 2024-12-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BCTG Holdings, LLCReported CIK 0001823427

    Shares: 0 · Class: 0%

  • MVA Investors, LLCReported CIK 0001468223

    Shares: 326,886 · Class: 0.3%

  • Davis Aaron I.Reported CIK 0001465914

    Shares: 10,740,385 · Class: 10%

  • Boxer Capital Management, LLCReported CIK 0002018299

    Shares: 10,380,999 · Class: 9.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895345-25-000001
Form type
SCHEDULE 13D/A
Filer
BCTG Holdings, LLC
CIK
CIK 1823427
Filed
Jan 02, 2025
Reporting period
Dec 30, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub